KRAS-dependent sorting of miRNA to exosomes

eLife

Volumn 4, Issue JULY 2015, 2015, Pages

  Cha, Diana J ^a,b   Franklin, Jeffrey L ^a,c,d   Dou, Yongchao ^a   Liu, Qi ^a   Higginbotham, James N ^a,c   Beckler, Michelle Demory ^a   Weaver, Alissa M ^a,c   Vickers, Kasey ^a   Prasad, Nirpesh ^e   Levy, Shawn ^e   Zhang, Bing ^a   Coffey, Robert J ^a,c,d   Patton, James G ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Affairs Medical Center   (United States)

^e HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 100; SPHINGOMYELIN PHOSPHODIESTERASE; KRAS PROTEIN, HUMAN; PROTEIN P21;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL INTERACTION; CLUSTER ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; EXOSOME; GENE EXPRESSION; GENE REPRESSION; NONHUMAN; PROTEIN FOLDING; PROTEIN TARGETING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION; CELL CULTURE TECHNIQUE; CELL LINE; HUMAN; METABOLISM; SECRETION (PROCESS); TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL CULTURE TECHNIQUES; CELL LINE; EXOSOMES; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 84938412771     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.07197     Document Type: Article

References (69)

1. Alvarez-Garcia I, Miska EA. 2005. MicroRNA functions in animal development and human disease. Development 132:4653–4662. doi: 10.1242/dev.02073.
2. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biology 11:R106. doi: 10.1186/gb-2010-11-10-r106.
3. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of USA 108:5003–5008. doi: 10.1073/pnas.1019055108.
4. Baccarini A, Chauhan H, Gardner TJ, Jayaprakash AD, Sachidanandam R, Brown BD. 2011. Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Current Biology 21:369–376. doi: 10.1016/j.cub.2011.01.067.
5. Bartel DP, Chen CZ. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nature Reviews. Genetics 5:396–400. doi: 10.1038/nrg1328.
6. Batagov AO, Kuznetsov VA, Kurochkin IV. 2011. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 12(Suppl 3):S18. doi: 10.1186/1471-2164-12-S3-S18.
7. Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y, Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, Ter Brugge PJ, Jonkers J, Slingerland J, Minn AJ. 2014. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell 159:499–513. doi: 10.1016/j.cell.2014.09.051.
8. Bolukbasi MF, Mizrak A, Ozdener GB, Madlener S, Ströbel T, Erkan EP, Fan J-B, Breakefield XO, Saydam O. 2012. miR-1289 and “Zipcode”-like sequence enrich mRNAs in microvesicles. Molecular Therapy. Nucleic Acids 1:e10. doi: 10.1038/mtna.2011.2.
9. Burge SW, Daub J, Eberhardt R, Tate J, Barquist L, Nawrocki EP, Eddy SR, Gardner PP, Bateman A. 2013. Rfam 11.0: 10 years of RNA families. Nucleic Acids Research 41:D226–D232. doi: 10.1093/nar/gks1005.
10. Burroughs AM, Ando Y, de Hoon MJ, Tomaru Y, Nishibu T, Ukekawa R, Funakoshi T, Kurokawa T, Suzuki H, Hayashizaki Y, Daub CO. 2010. A comprehensive survey of 3’ animal miRNA modification events and a possible role for 3’ adenylation in modulating miRNA targeting effectiveness. Genome Research 20:1398–1410. doi: 10.1101/gr.106054.110.
11. Chen CJ, Servant N, Toedling J, Sarazin A, Marchais A, Duvernois-Berthet E, Cognat V, Colot V, Voinnet O, Heard E, Ciaudo C, Barillot E. 2012. ncPRO-seq: a tool for annotation and profiling of ncRNAs in sRNA-seq data. Bioinformatics 28:3147–3149. doi: 10.1093/bioinformatics/bts587.
12. Chen X, Liang H, Zhang J, Zen K, Zhang CY. 2013. microRNAs are ligands of Toll-like receptors. RNA 19:737–739. doi: 10.1261/rna.036319.112.
13. Chen D, Sun Y, Yuan Y, Han Z, Zhang P, Zhang J, You MJ, Teruya-Feldstein J, Wang M, Gupta S, Hung MC, Liang H, Ma L. 2014. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. PLOS Genetics 10:e1004177. doi: 10.1371/journal.pgen.1004177.
14. Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, Cheng HH, Arroyo JD, Meredith EK, Gallichotte EN, Pogosova-Agadjanyan EL, Morrissey C, Stirewalt DL, Hladik F, Yu EY, Higano CS, Tewari M. 2014. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proceedings of the NationalAcademy of Sciences of USA 111:14888–14893. doi: 10.1073/pnas.1408301111.
15. Chong MM, Zhang G, Cheloufi S, Neubert TA, Hannon GJ, Littman DR. 2010. Canonical and alternate functions of the microRNA biogenesis machinery. Genes & Development 24:1951–1960. doi: 10.1101/gad.1953310.
16. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, García-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen TL, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D. 2015. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology 17:816–826. doi: 10.1038/ncb3169.
17. Crescitelli R, Lasser C, Szabo TG, Kittel A, Eldh M, Dianzani I, Buzas EI, Lotvall J. 2013. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. Journal of Extracellular Vesicles 2. doi: 10.3402/jev.v2i0.20677.
18. Demory Beckler M, Higginbotham JN, Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M, Liebler DC, Coffey RJ. 2013. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Molecular & Cellular Proteomics 12:343–355. doi: 10.1074/mcp.M112.022806.
19. Ekstrom K, Valadi H, Sjostrand M, Malmhall C, Bossios A, Eldh M, Lotvall J. 2012. Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. Journal of Extracellular Vesicles 1:18389. doi: 10.3402/jev.v1i0.18389.
20. Emmrich S, Rasche M, Schoning J, Reimer C, Keihani S, Maroz A, Xie Y, Li Z, Schambach A, Reinhardt D, Klusmann JH. 2014. miR-99a/100∼125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFbeta and Wnt signaling. Genes & Development 28:858–874. doi: 10.1101/gad.233791.113.
21. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CM. 2012. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences of USA 109:E2110–E2116. doi: 10.1073/pnas.1209414109.
22. Faller WJ, Jackson TJ, Knight JR, Ridgway RA, Jamieson T, Karim SA, Jones C, Radulescu S, Huels DJ, Myant KB, Dudek KM, Casey HA, Scopelliti A, Cordero JB, Vidal M, Pende M, Ryazanov AG, Sonenberg N, Meyuhas O, Hall MN, Bushell M, Willis AE, Sansom OJ. 2015. mTORC1-mediated translational elongation limits intestinal tumour initiation and growth. Nature 517:497–500. doi: 10.1038/nature13896.
23. Gardner PP, Daub J, Tate J, Moore BL, Osuch IH, Griffiths-Jones S, Finn RD, Nawrocki EP, Kolbe DL, Eddy SR, Bateman A. 2011. Rfam: wikipedia, clans and the "decimal" release. Nucleic Acids Research 39:D141–D145. doi: 10.1093/nar/gkq1129.
24. Ge YY, Shi Q, Zheng ZY, Gong J, Zeng C, Yang J, Zhuang SM. 2014. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R. Oncotarget 5:6218–6228.
25. Gebeshuber CA, Martinez J. 2013. miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling. Oncogene 32:3306–3310. doi: 10.1038/onc.2012.372.
26. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Research 34:D140–D144. doi: 10.1093/nar/gkj112.
27. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Research 36:D154–D158. doi: 10.1093/nar/gkm952.
28. Griffiths-Jones S. 2010. miRBase: microRNA sequences and annotation. In: Andreas D Baxevanis, William R Pearson, Lincoln D Stein, Gary D Stormo, John R Yates III, editors. Current protocols in bioinformatics/editoral board. Chapter 12Unit 12.
29. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, Sluijter JP, Hoefer I, Pasterkamp G, Bode C, Moser M. 2011. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 123:999–1009. doi: 10.1161/CIRCULATIONAHA.110.000323.
30. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ. 2011. Amphiregulin exosomes increase cancer cell invasion. Current Biology 21:779–786. doi: 10.1016/j.cub.2011.03.043.
31. Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM. 2013. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports 5:1159–1168. doi: 10.1016/j.celrep.2013.10.050.
32. Hsieh IS, Chang KC, Tsai YT, Ke JY, Lu PJ, Lee KH, Yeh SD, Hong TM, Chen YL. 2013. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis 34:530–538. doi: 10.1093/carcin/bgs371.
33. Ji H, Chen M, Greening DW, He W, Rai A, Zhang W, Simpson RJ. 2014. Deep sequencing of RNA from three different extracellular vesicle (EV) subtypes released from the human LIM1863 colon cancer cell line uncovers distinct miRNA-enrichment signatures. PLOS ONE 9:e110314. doi: 10.1371/journal.pone.0110314.
34. Kahlert C, Kalluri R. 2013. Exosomes in tumor microenvironment influence cancer progression and metastasis. Journal of Molecular Medicine 91:431–437. doi: 10.1007/s00109-013-1020-6.
35. Koppers-Lalic D, Hackenberg M, Bijnsdorp IV, van Eijndhoven MA, Sadek P, Sie D, Zini N, Middeldorp JM, Ylstra B, de Menezes RX, Würdinger T, Meijer GA, Pegtel DM. 2014. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Reports 8:1649–1658. doi: 10.1016/j.celrep.2014.08.027.
36. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. 2010. Secretory mechanisms and intercellular transfer of microRNAs in living cells. The Journal of Biological Chemistry 285:17442–17452. doi: 10.1074/jbc.M110.107821.
37. Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nature Reviews. Genetics 11:597–610. doi: 10.1038/nrg2843.
38. LaConti JJ, Shivapurkar N, Preet A, Deslattes Mays A, Peran I, Kim SE, Marshall JL, Riegel AT, Wellstein A. 2011. Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLOS ONE 6:e20687. doi: 10.1371/journal.pone.0020687.
39. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nature Methods 9:357–359. doi: 10.1038/nmeth.1923.
40. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834–838. doi: 10.1038/nature03702.
41. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL. 2012. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151:1542–1556. doi: 10.1016/j.cell.2012.11.024.
42. Ma L. 2010. Role of miR-10b in breast cancer metastasis. Breast Cancer Research 12:210. doi: 10.1186/bcr2720.
43. Martin M. 2011. Cutadapt removes adapator sequences from high-throughput sequencing reads. EMBnet.Journal 17:10–12. doi: 10.14806/ej.17.1.200.
44. Melo SA, Sugimoto H, O’Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, Lucci A, Ivan C, Calin GA, Kalluri R. 2014. Cancer exosomes perform cell-independent MicroRNA biogenesis and promote tumorigenesis. Cancer Cell 26:707–721. doi: 10.1016/j.ccell.2014.09.005.
45. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F. 2011. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigenpresenting cells. Nature Communications 2:282. doi: 10.1038/ncomms1285.
46. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE. 2012. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119: 756–766. doi: 10.1182/blood-2011-02-338004.
47. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM, Anderson ML, Matzuk MM. 2010. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Molecular Endocrinology 24:447–463. doi: 10.1210/me.2009-0295.
48. Neilsen CT, Goodall GJ, Bracken CP. 2012. IsomiRs–the overlooked repertoire in the dynamic microRNAome. Trends in Genetics 28:544–549. doi: 10.1016/j.tig.2012.07.005.
49. Newman MA, Mani V, Hammond SM. 2011. Deep sequencing of microRNA precursors reveals extensive 3’ end modification. RNA 17:1795–1803. doi: 10.1261/rna.2713611.
50. Palma J, Yaddanapudi SC, Pigati L, Havens MA, Jeong S, Weiner GA, Weimer KM, Stern B, Hastings ML, Duelli DM. 2012. MicroRNAs are exported from malignant cells in customized particles. Nucleic Acids Research 40: 9125–9138. doi: 10.1093/nar/gks656.
51. Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S. 2012. Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene 31:4517–4526. doi: 10.1038/onc.2011.631.
52. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biology 11:R25. doi: 10.1186/gb-2010-11-3-r25.
53. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Ørntoft TF, Andersen CL. 2008. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Research 68:6416–6424. doi: 10.1158/0008-5472.CAN-07-6110.
54. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85–88. doi: 10.1126/science.8465203.
55. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO. 2008. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth andprovide diagnostic biomarkers. Nature Cell Biology 10:1470–1476. doi: 10.1038/ncb1800.
56. Squadrito ML, Baer C, Burdet F, Maderna C, Gilfillan GD, Lyle R, Ibberson M, De Palma M. 2014. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Reports 8:1432–1446. doi: 10.1016/j.celrep.2014.07.035.
57. Tarasov VA, Matishov DG, Shin EF, Boyko NV, Timoshkina NN, Makhotkin MA, Lomonosov AM, Kirpiy AA, Kit OI, Maximov AY. 2014. Coordinated aberrant expression of miRNAs in colon cancer. Genetika 50:1090–1101. doi: 10.1134/S1022795414080109.
58. Tehler D, Hoyland-Kroghsbo NM, Lund AH. 2011. The miR-10 microRNA precursor family. RNA Biology 8:728–734. doi: 10.4161/rna.8.5.16324.
59. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. 2006. Extensive posttranscriptional regulation of microRNAs and its implications for cancer. Genes & Development 20:2202–2207. doi: 10.1101/gad.1444406.
60. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. 2007. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 9:654–659. doi: 10.1038/ncb1596.
61. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biology 13:423–433. doi: 10.1038/ncb2210.
62. Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, Martinez-Herrera DJ, Pascual-Montano A, Mittelbrunn M, Sanchez-Madrid F. 2013. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications 4: 2980. doi: 10.1038/ncomms3980.
63. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of USA 103:2257–2261. doi: 10.1073/pnas.0510565103.
64. Wang M, Ren D, Guo W, Wang Z, Huang S, Du H, Song L, Peng X. 2014. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. International Journal of Oncology 45:362–372. doi: 10.3892/ijo.2014.2413.
65. Wei C, Salichos L, Wittgrove CM, Rokas A, Patton JG. 2012. Transcriptome-wide analysis of small RNA expression in early zebrafish development. RNA 18:915–929. doi: 10.1261/rna.029090.111.
66. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RHA. 2005. MicroRNA expression in zebrafish embryonic development. Science 309:310–311. doi: 10.1126/science.1114519.
67. Wong R, Cunningham D. 2008. Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. Journal of Clinical Oncology 26:5668–5670. doi: 10.1200/JCO.2008.19.5024.
68. Xie M, Li M, Vilborg A, Lee N, Shu MD, Yartseva V, Sestan N, Steitz JA. 2013. Mammalian 5’-capped microRNA precursors that generate a single microRNA. Cell 155:1568–1580. doi: 10.1016/j.cell.2013.11.027.
69. Zhou MK, Liu XJ, Zhao ZG, Cheng YM. 2015. MicroRNA-100 functions as a tumor suppressor by inhibiting Lgr5 expression in colon cancer cells. Molecular Medicine Reports 11:2947–2952. doi: 10.3892/mmr.2014.3052.